Oramed Pharmaceuticals Inc. (ORMP): Total Assets
$230.86M
As of 2025-12-31
$369.64M
As of 2026-06-30
+12.6%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $230.86M | +48.7% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $155.28M | -29.6% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $220.55M | +36.4% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $161.64M | -9.1% | 2024-03-06, Balance as of period end |
| 2021-12-31 | $177.82M | n/a | 2023-03-06, Balance as of period end |
| 2021-08-31 | $128.00M | +186.8% | 2021-11-24, Balance as of period end |
| 2020-08-31 | $44.63M | +28.8% | 2021-11-24, Balance as of period end |
| 2019-08-31 | $34.66M | -26.9% | 2020-11-24, Balance as of period end |
| 2018-08-31 | $47.40M | +22.4% | 2019-11-27, Balance as of period end |
| 2017-08-31 | $38.71M | -9.6% | 2018-11-28, Balance as of period end |
| 2016-08-31 | $42.83M | +62.5% | 2017-11-29, Balance as of period end |
| 2015-08-31 | $26.35M | +20.9% | 2016-11-25, Balance as of period end |
| 2014-08-31 | $21.80M | +151.8% | 2015-11-25, Balance as of period end |
| 2013-08-31 | $8.66M | +63.6% | 2014-11-14, Balance as of period end |
| 2012-08-31 | $5.29M | +22.4% | 2013-11-27, Balance as of period end |
| 2011-08-31 | $4.33M | n/a | 2012-12-12, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Oramed Pharmaceuticals Inc. (ORMP) | 2025-12-31 | $230.86M | +48.7% |
| Immuneering Corp (IMRX) | 2025-12-31 | $231.99M | +340.1% |
| Design Therapeutics, Inc. (DSGN) | 2025-12-31 | $226.20M | -10.3% |
| Evolus, Inc. (EOLS) | 2025-12-31 | $225.87M | -2.9% |
| Pliant Therapeutics, Inc. (PLRX) | 2025-12-31 | $225.23M | -43.3% |
| Evommune, Inc. (EVMN) | 2025-12-31 | $224.95M | +195.8% |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | $239.34M | -5.8% |
| Crescent Biopharma, Inc. (CBIO) | 2025-12-31 | $240.29M | +574.7% |
| Abeona Therapeutics Inc. (ABEO) | 2025-12-31 | $219.57M | +101.6% |
Compare ORMP, IMRX, DSGN, EOLS side by side · Screen every company in Pharmaceutical Preparations ↗